These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34258983)

  • 21. Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes.
    Danese E; Montagnana M; Nouvenne A; Lippi G
    J Diabetes Sci Technol; 2015 Mar; 9(2):169-76. PubMed ID: 25591856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol.
    Selvin E; Warren B; He X; Sacks DB; Saenger AK
    Clin Chem; 2018 May; 64(5):843-850. PubMed ID: 29436378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.
    Chan CL; Pyle L; Kelsey M; Newnes L; Zeitler PS; Nadeau KJ
    Pediatr Diabetes; 2016 May; 17(3):206-11. PubMed ID: 25652226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.
    Selvin E; Rawlings AM; Grams M; Klein R; Sharrett AR; Steffes M; Coresh J
    Lancet Diabetes Endocrinol; 2014 Apr; 2(4):279-288. PubMed ID: 24703046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-Wide Association Study of Serum Fructosamine and Glycated Albumin in Adults Without Diagnosed Diabetes: Results From the Atherosclerosis Risk in Communities Study.
    Loomis SJ; Li M; Maruthur NM; Baldridge AS; North KE; Mei H; Morrison A; Carson AP; Pankow JS; Boerwinkle E; Scharpf R; Rasmussen-Torvik LJ; Coresh J; Duggal P; Köttgen A; Selvin E
    Diabetes; 2018 Aug; 67(8):1684-1696. PubMed ID: 29844224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ratio of glycated albumin to hemoglobin A1c measured in IFCC units accurately represents the glycation gap.
    Akatsuka J; Mochizuki M; Musha I; Ohtake A; Kobayashi K; Kikuchi T; Kikuchi N; Kawamura T; Urakami T; Sugihara S; Hoshino T; Amemiya S;
    Endocr J; 2015; 62(2):161-72. PubMed ID: 25367400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level.
    Tahara Y; Shima K
    Diabetes Care; 1995 Apr; 18(4):440-7. PubMed ID: 7497851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycated albumin in diabetic patients with chronic kidney disease.
    Zheng CM; Ma WY; Wu CC; Lu KC
    Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of body mass index with glycated albumin and glycated albumin/glycated hemoglobin A
    He X; Mo Y; Ma X; Ying L; Zhu W; Wang Y; Bao Y; Zhou J
    Clin Chim Acta; 2018 Sep; 484():117-121. PubMed ID: 29802831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for cystic fibrosis-related diabetes and prediabetes: Evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c.
    Tommerdahl KL; Brinton JT; Vigers T; Nadeau KJ; Zeitler PS; Chan CL
    Pediatr Diabetes; 2019 Dec; 20(8):1080-1086. PubMed ID: 31469470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
    Kaminski CY; Galindo RJ; Navarrete JE; Zabala Z; Moazzami B; Gerges A; McCoy RG; Fayfman M; Vellanki P; Idrees T; Peng L; Umpierrez GE
    Diabetes Care; 2024 Feb; 47(2):267-271. PubMed ID: 38085705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The agreement between fasting glucose and markers of chronic glycaemic exposure in individuals with and without chronic kidney disease: a cross-sectional study.
    George C; Matsha TE; Korf M; Zemlin AE; Erasmus RT; Kengne AP
    BMC Nephrol; 2020 Jan; 21(1):32. PubMed ID: 32000712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association and discordance between glycated hemoglobin A1c and glycated albumin, assessed using a blend of multiple linear regression and random forest regression.
    Zeng Y; He H; Zhou J; Zhang M; Huang H; An Z
    Clin Chim Acta; 2020 Jul; 506():44-49. PubMed ID: 32169421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.
    Kobayashi H; Abe M; Yoshida Y; Suzuki H; Maruyama N; Okada K
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
    Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
    Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated serum glycated albumin and glycated albumin : hemoglobin A
    Ohara T; Furuta Y; Hirabayashi N; Hata J; Hirakawa Y; Honda T; Yoshida D; Shibata M; Kitazono T; Ninomiya T
    J Diabetes Investig; 2020 Jul; 11(4):971-979. PubMed ID: 31999889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
    Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
    Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)].
    Sato A
    Rinsho Byori; 2014 Jan; 62(1):45-52. PubMed ID: 24724426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of hemoglobin H (HbH) disease with hemoglobin A
    He D; Kuang W; Yang X; Xu M
    Clin Chem Lab Med; 2021 May; 59(6):1127-1132. PubMed ID: 33554549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.